MedTrace Logo

Does Muscle Mass At Intensive Care Unit Admission Determine Mortality: the Memo Study

NCT05834894 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2024-12-06

No results posted yet for this study

Summary

This retrospective monocentric study aims to investigate whether a low muscle mass at ICU admission and its loss over the ICU stay predicts mortality, and in what proportion we can counteract it by nutritional support.

Conditions

  • Lean Body Mass

Interventions

OTHER

exposure(s) of interest : intensive care unit

Low muscle mass is highly prevalent at hospital admission, and muscle mass generally decreases during hospital stay, especially in critically-ill patients. We would like to mesure muscle mas in critically ill patients and determine the association between outcomes.

Sponsors & Collaborators

  • VBertoniMaluf

    collaborator UNKNOWN

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Laurence Genton, MD · University Hospital, Geneva

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2025-05-31
Completion
2025-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05834894 on ClinicalTrials.gov